ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 29 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $159,000 | -6.5% | 50,604 | +2.0% | 0.00% | – |
| Q3 2016 | $170,000 | +22.3% | 49,588 | -0.4% | 0.00% | – |
| Q2 2016 | $139,000 | -43.3% | 49,806 | +24.7% | 0.00% | – |
| Q1 2016 | $245,000 | +5.2% | 39,938 | -7.5% | 0.00% | – |
| Q4 2015 | $233,000 | +42.9% | 43,176 | +2.8% | 0.00% | – |
| Q3 2015 | $163,000 | -9.9% | 41,993 | -2.6% | 0.00% | – |
| Q2 2015 | $181,000 | +21.5% | 43,103 | +13.7% | 0.00% | – |
| Q1 2015 | $149,000 | – | 37,903 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |